Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
NCT00745316 is registered in ClinicalTrials.gov with Biogen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
- Lead sponsor
- Biogen
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- February 28, 2009
- Completion date
- January 31, 2010
- Enrollment
- 34 (actual)
- Sites
- 30
Conditions
As the registry lists them; a condition with its own page is linked.